SABCS 2022 EMERALD Phase 3 Trial Updated Results by Duration of Prior CDK4/6i: Elacestrant vs. SoC ET in Patients With ER+/HER2- mBC
By
SABCS 2022 Conference Coverage
FEATURING
Hung Khong
December 14, 2022
This video was recorded prior to FDA approval of ORSERDU™ (elacestrant) on January 27, 2023 ...
read more ↘
read more ↘
Login to view comments.
Click here to Login
